← Back to Search

Behavioural Intervention

Training Group 1 for Mild Cognitive Impairment (CogTraining Trial)

N/A

Waitlist Available

Led By Joel Sneed, PhD

Research Sponsored by New York State Psychiatric Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up [time frame: screen, weeks 12, 32 52, 78]

Awards & highlights

CogTraining Trial Summary

This trial will evaluate if systematic cognitive training can improve the cognitive performance of 55+ year olds with memory loss. CCT will be used to test for improvements in everyday cognitive function and brain networks over an 18-month period. There is no medication distribution for this study.

Eligible Conditions

Mild Cognitive Impairment
Memory Loss
Cognitive Decline
Cognitive Impairment
Cognitive Disorders

CogTraining Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ [time frame: screen]

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~[time frame: screen]

This trial's timeline: 3 weeks for screening, Varies for treatment, and [time frame: screen] for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change overtime in the Alzheimer's Disease Assessment Scale-Cognitive (ADAS-Cog)

Secondary outcome measures

Change overtime in Pfeffer Functional Activities Questionnaire (FAQ)

Change overtime in the Neurocognitive Performance Test

Neuropsychological Testing Composite Score

+1 more

Other outcome measures

Block Design

Boston Naming Task

Cognitive Reserve Index

+11 more

CogTraining Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: Training Group 1Active Control1 Intervention

Computerized Cognitive Training

Group II: Training Group 2Placebo Group1 Intervention

Crossword puzzles

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Duke UniversityOTHER

2,360 Previous Clinical Trials

3,420,223 Total Patients Enrolled

Queens College, The City University of New YorkOTHER

12 Previous Clinical Trials

11,180 Total Patients Enrolled

New York State Psychiatric InstituteLead Sponsor

475 Previous Clinical Trials

153,800 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it currently possible to enroll in this research endeavor?

"According to clinicaltrials.gov, this medical trial is no longer recruiting participants at the moment; it was first posted on November 29th 2017 and last updated October 3rd 2022. Nevertheless, there are 1,547 other active studies that are currently looking for individuals to enroll in their research."

Answered by AI

Does eligibility for this research encompass individuals older than twenty years?

"Patients aged 55 to 95 may be able to participate in this medical trial. Notably, there are 274 studies open for individuals under 18 and 1199 trials available for those above 65 years of age."

Answered by AI

Who is eligible to be included in this research project?

"This trial seeks out 107 elderly individuals, aged 55 to 95, who experience cognitive decline such as memory loss. To qualify for the study, patients must provide subjective complaints regarding their cognition; have a Wechsler Memory Scale (WMS) III Logical Memory score lower than standardized norms; get a Folstein Mini Mental State Examination result of 23 or higher out of 30; and possess access to an adequate internet-connected laptop or desktop computer throughout the duration of the research. Additionally, they need a family member or close significant other willing to act as informant during this clinical investigation."

Answered by AI